These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15853591)

  • 1. Adiposopathy: role of adipocyte factors in a new paradigm.
    Bays H
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):187-9. PubMed ID: 15853591
    [No Abstract]   [Full Text] [Related]  

  • 2. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
    Bays H; Blonde L; Rosenson R
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):871-95. PubMed ID: 17173503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of Everything.
    Bays H
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):393-404. PubMed ID: 15889967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases?
    Bini S; D'Erasmo L; Di Costanzo A; Minicocci I; Pecce V; Arca M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endocrine-dependent metabolic disorders in the female and male climacteric].
    Knick B
    Med Welt; 1974 Feb; 25(6):210-2. PubMed ID: 4813274
    [No Abstract]   [Full Text] [Related]  

  • 7. Preface. Adiposopathy in cancer and (cardio)metabolic diseases: an endocrine approach - Part 1.
    Chetrite GS; Fève B
    Horm Mol Biol Clin Investig; 2014 Oct; 20(1):1-2. PubMed ID: 25460289
    [No Abstract]   [Full Text] [Related]  

  • 8. Preface to special issue on: Adiposopathy in cancer and (cardio)metabolic diseases: an endocrine approach - Part 3.
    Chetrite GS; Fève B
    Horm Mol Biol Clin Investig; 2015 Apr; 22(1):3-5. PubMed ID: 26011938
    [No Abstract]   [Full Text] [Related]  

  • 9. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
    Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Here, there and everywhere: the endocannabinoid system.
    Vettor R; Pagotto U; Pagano C; Pasquali R
    J Neuroendocrinol; 2008 May; 20 Suppl 1():iv-vi. PubMed ID: 18426491
    [No Abstract]   [Full Text] [Related]  

  • 11. Preface to special issue on: Adiposopathy in Cancer and (Cardio)Metabolic Diseases: an Endocrine Approach - Part 4.
    Chetrite GS; Fève B
    Horm Mol Biol Clin Investig; 2015 Jul; 23(1):1-4. PubMed ID: 26353175
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status.
    Poitou C; Coussieu C; Rouault C; Coupaye M; Cancello R; Bedel JF; Gouillon M; Bouillot JL; Oppert JM; Basdevant A; Clément K
    Obesity (Silver Spring); 2006 Feb; 14(2):309-18. PubMed ID: 16571858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects associated with adipose tissue distribution.
    Zahorska-Markiewicz B
    Adv Med Sci; 2006; 51():111-4. PubMed ID: 17357288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women.
    Lee K; Lee S; Kim YJ; Kim YJ
    Nutrition; 2008; 24(7-8):625-31. PubMed ID: 18485667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue as source and target for novel therapies.
    Klein J; Perwitz N; Kraus D; Fasshauer M
    Trends Endocrinol Metab; 2006; 17(1):26-32. PubMed ID: 16309918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of adipose tissue-derived factors in obesity.
    Umpaichitra V
    Pediatr Endocrinol Rev; 2006 Dec; 3 Suppl 4():537-43. PubMed ID: 17237740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A putative role for apelin in the etiology of obesity.
    Rayalam S; Della-Fera MA; Krieg PA; Cox CM; Robins A; Baile CA
    Biochem Biophys Res Commun; 2008 Apr; 368(3):815-9. PubMed ID: 18275845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistin- and Obesity-associated metabolic diseases.
    Lazar MA
    Horm Metab Res; 2007 Oct; 39(10):710-6. PubMed ID: 17952831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
    Kunos G
    Am J Med; 2007 Sep; 120(9 Suppl 1):S18-24; discussion S24. PubMed ID: 17720356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.